دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of contents
doi : 10.1016/S0190-9622(24)00142-7
Volume 90, Issue 4, April 2024, Pages A4, A7-A10, A12-A16, A25-A27
Information for readers
doi : 10.1016/S0190-9622(24)00143-9
Volume 90, Issue 4, April 2024, Page A28
JAAD Case Reports article list
doi : 10.1016/S0190-9622(24)00144-0
Volume 90, Issue 4, April 2024, Pages A29-A31
Journal based CME instructions and information
doi : 10.1016/S0190-9622(24)00145-2
Volume 90, Issue 4, April 2024, Page A32
Performance measurement part I: Foundational knowledge for measure development
Tatiana Abrantes, MD, a Dillon Imbriano, BS, b Daniella Reimann, MD, c Janet Sullivan, MD, d Oliver Wisco, DO, a Stephanie Chan, BS, a Christopher DiMarco, MD, a Nicole Gehret, BA, a Nicole Grenier, MD, a Paul Imbriano, DO, e Benjamin Kahn, MD, a Leonardo Lizbinski, MPH, MSc, a Cathy Massoud, MD, a Nicole Negbenebor, MD, a Sylvia Parra, MD, f Deven Patel, BS, g Margo Reeder, MD, h Allison Robbins, MD, a Junko Takeshita, MD, PhD, MSCE, i Eric J. Yang, MD, a Stephanie C. Braxton, MPH, j and Dirk Elston, MD
doi : 10.1016/j.jaad.2023.01.054
Volume 90, Issue 4, April 2024, Pages 681-689
Answers to CME examination
doi : 10.1016/j.jaad.2024.01.044
Volume 90, Issue 4, April 2024, Page 692
Performance measurement part II: AÂ guide to developing dermatology performance measures
Daniella Reimann, MD, a Dillon Imbriano, DO, b Tatiana Abrantes, BS, c Janet Sullivan, MD, d Oliver Wisco, DO, c Stephanie Chan, BS, c Christopher Dimarco, MD, c Nicole Gehret, BA, c Nicole Grenier, MD, c Paul Imbriano, DO, e Benjamin Kahn, MD, c Leonardo Lizbinski, MPH, MSc, c Cathy Massoud, MD, c Nicole Negbenebor, MD, c Sylvia Parra, MD, f Deven Patel, BS, g Margo Reeder, MD, h Allison Robbins, MD, c Junko Takeshita, MD, PhD, MSCE, i Eric J. Yang, MD, c Stephanie C. Braxton, MPH, j and Dirk Elston, MD
doi : 10.1016/j.jaad.2023.02.069
Volume 90, Issue 4, April 2024, Pages 693-701
Answers to CME examination
doi : 10.1016/j.jaad.2024.01.046
Volume 90, Issue 4, April 2024, Page 704
Letter from the editor: Avoiding delays in emergent treatment of generalized pustular psoriasis
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.07.1049
Volume 90, Issue 4, April 2024, Pages 705-706
The road to publication: Advice from journal editors
Cristian Navarrete-Dechent, MD, a Karalikkattil T. Ashique, DDVL, PGDHS, FRCP, b John R. Ingram, MA, MSc, DM(Oxon), FRCP(Derm), FAcadMEd, c Lidia Rudnicka, MD, d Yolanda Gilaberte, MD, e Johannes Ring, MD, f Dedee F. Murrell, MA(Cambridge), BMBCh (Oxford), FAAD (USA), MD (UNSW), FACD, FRCP (Edin), DSc (Oxford), g,h Dirk Elston, MD, i and Bruce H. Thiers, MD
doi : 10.1016/j.jaad.2023.11.038
Volume 90, Issue 4, April 2024, Pages 707-710
This month in JAAD: April 2024
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2024.01.019
Volume 90, Issue 4, April 2024, Page 711
This Month in JAAD Case Reports: April 2024: Anifrolumab for subacute cutaneous lupus
Brett Sloan, MD
doi : 10.1016/j.jaad.2024.01.015
Volume 90, Issue 4, April 2024, Page 712
This Month in JAAD International - April 2024
Jonathan Kantor, MD, MSc, MSCE
doi : 10.1016/j.jaad.2024.01.055
Volume 90, Issue 4, April 2024, Page 713
The expanding horizon of anti-IL-36 therapy
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2024.01.034
Volume 90, Issue 4, April 2024, Pages 714-715
JAAD Game Changer: Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.09.005
Volume 90, Issue 4, April 2024, Page 715
Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study
Elena B. Hawryluk, MD, PhD, a,b,c Danna Moustafa, MD, a,c Kelly K. Barry, MD, d Eman Bahrani, MD, e Diana B. Reusch, MD, a,b,c Meera Brahmbhatt, MD, f Lily Chen, MD, g Carrie C. Coughlin, MD, g Pedram Gerami, MD, h Ellen Haddock, MD, i Kristen Hook, MD, j Stephen R. Humphrey, MD, k Pei-Chi Kao, MPH, l,m Lacey L. Kruse, MD, h,n Leslie P. Lawley, MD, f Danny Mansour, MD, o,p Ashfaq A. Marghoob, MD, q Julie Nguyen, MD, e Thuy L. Phung, MD, PhD, r Elena Pope, MD, MSc, o,p Tom Raisanen, MD, j Sarah Robinson, MD, s Tova Rogers, MD, q Birgitta Schmidt, MD, c,t Gary Tran, MD, h Kate Travis, MD, e Zachary Wolner, MD, f Wendy B. London, PhD, c,l,m Lawrence F. Eichenfield, MD, i,u and Jennifer Huang, MD
doi : 10.1016/j.jaad.2023.10.067
Volume 90, Issue 4, April 2024, Pages 716-726
JAAD Game Changer: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.09.006
Volume 90, Issue 4, April 2024, Page 726
Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation
April W. Armstrong, MD, MPH, a Carly A. Elston, MD, b Boni E. Elewski, MD, b Laura K. Ferris, MD, PhD, c Alice B. Gottlieb, MD, PhD, d Mark G. Lebwohl, MD, d and the Medical Board of the National Psoriasis Foundation
doi : 10.1016/j.jaad.2023.09.080
Volume 90, Issue 4, April 2024, Pages 727-730
Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study
Emily E. Granger, BS, a Morgan Groover, BS, a Catherine Harwood, MA, PhD, b Charlotte M. Proby, MA, MRCP, c Emily Karn, MS, a Fadi Murad, MD, MPH, a Chrysalyne D. Schmults, MD, MScE, a and Emily S. Ruiz, MD, MPH
doi : 10.1016/j.jaad.2023.11.039
Volume 90, Issue 4, April 2024, Pages 731-738
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study
Nikolaus B. Wagner, MD, a,b Sarah M. Knierim, BS, a Felix Luttermann, MD, b Gisela Metzler, MD, b,c Amir S. Yazdi, MD, b,d J€urgen Bauer, MD, b Maximilian Gassenmaier, MD, b,e Andrea Forschner, MD, b Ulrike Leiter, MD, b Teresa Amaral, MD, PhD, b Claus Garbe, MD, b Thomas K. Eigentler, MD, b,f Stephan Forchhammer, MD, b and Lukas Flatz, MD
doi : 10.1016/j.jaad.2023.11.040
Volume 90, Issue 4, April 2024, Pages 739-748
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa
Kristina Navrazhina, MD, PhD, a,b Yael Renert-Yuval, MD, MSc, b,c,d Saakshi Khattri, MD, a Hassan Hamade, MD, a Marguerite Meariman, MD, a Elizabeth Andrews, MD, a Madeline Kim, BA, a Monali NandyMazumdar, PhD, a Digpal S. Gour, PhD, a Swaroop Bose, MS, a Samuel C. Williams, BA, a Sandra Garcet, PhD, a Joel Correa da Rosa, PhD, a Alice B. Gottlieb, MD, PhD, a James G. Krueger, MD, PhD, b and Emma Guttman-Yassky, MD, PhD a
doi : 10.1016/j.jaad.2023.11.048
Volume 90, Issue 4, April 2024, Pages 749-758
JAAD Game Changer: Relative efficacy of systemic treatments for atopic dermatitis
Robert T. Brodell, MD
doi : 10.1016/j.jaad.2023.09.007
Volume 90, Issue 4, April 2024, Page 758
Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study
Elle Wang, MSc, a,b Tashmeeta Ahad, MD, a,b Yi. A. Liu, MD, c Tim K. Lee, PhD, a,b,d Harvey Lui, MD, a,b Richard I. Crawford, MD, c and Sunil Kalia, MD
doi : 10.1016/j.jaad.2023.11.053
Volume 90, Issue 4, April 2024, Pages 759-766
Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods
Patricia Richey, MD, a,b Margaret Funk, MS, a,b Fernanda Sakamoto, MD, PhD, a,b Scott Plotkin, MD, PhD, c Ina Ly, MD, PhD, c Justin Jordan, MD, c Alona Muzikansky, MA, d Josh Roberts, PhD, e William Farinelli, BS, a,b Yakir Levin, MD, PhD, a,b Lilit Garibyan, MD, PhD, a,b Jaishri O. Blakeley, MD, e and R. Rox Anderson, MD
doi : 10.1016/j.jaad.2023.11.058
Volume 90, Issue 4, April 2024, Pages 767-774
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis
Andrew Blauvelt, MD, MBA, a Phoebe Rich, MD, b Howard Sofen, MD, c Bruce Strober, MD, PhD, d,e Joseph F. Merola, MD, MMSc, f,g Mark Lebwohl, MD, h Akimichi Morita, MD, PhD, i Jacek C. Szepietowski, MD, PhD, j Jo Lambert, MD, PhD, k Lauren Hippeli, MS, l Elizabeth Colston, MD, PhD, l Eugene Balagula, MD, l Subhashis Banerjee, MD, l and Diamant Thac¸i, MD
doi : 10.1016/j.jaad.2023.11.060
Volume 90, Issue 4, April 2024, Pages 775-782
Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study
Luying Wang, MD, PhD, a,b Wenjing Wang, MM, b Zifu Zhou, MD, PhD, b Jing Li, MD, PhD, a Zhiyu Li, MD, PhD, b Renrong Lv, MD, a Guangqi Xu, MD, PhD, a Jianhai Bi, MD, PhD, a and Ran Huo, MD
doi : 10.1016/j.jaad.2023.12.034
Volume 90, Issue 4, April 2024, Pages 783-789
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz, PhD, a Manuela Pigors, PhD, a Tina Rastegar Lari, MD, a Christoph M. Hammers, MD, PhD, a,b Yao Wang, MSc, c Shirin Emtenani, PhD, a Monique Aumailley, MD, d Maike M. Holtsche, MD, b Felix H. Stang, MD, e Imke Weyers, MD, f Inke R. K€onig, PhD, g Cristina Has, MD, c Christiane Radzimski, PhD, h Lars Komorowski, PhD, h Detlef Zillikens, MD, b and Enno Schmidt, MD, PhD
doi : 10.1016/j.jaad.2023.11.014
Volume 90, Issue 4, April 2024, Pages 790-797
JAAD Game Changer: Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.09.008
Volume 90, Issue 4, April 2024, Page 797
Identifying critical quality metrics in Mohs Surgery: A national expert consensus process
Joseph A. Dodson, MD, a Sarah A. Ibrahim, MD, b Howard Rogers, MD, c M. Laurin Council, MD, d Kishwer S. Nehal, MD, e Rebecca Tung, MD, f David J. Leffell, MD, g Nathalie C. Zeitouni, MD, h Mariam B. Totonchy, MD, i Scott W. Fosko, MD, j Seaver Lee Soon, MD, k Travis W. Blalock, MD, l David G. Brodland, MD, m Elizabeth M. Billingsley, MD, n Jeffrey F. Scott, MD, o Brian C. Leach, MD, p Desiree Ratner, MD, q Carl Washington, MD, l,r C. William Hanke, MD, s,t,u Clark C. Otley, MD, v Nicholas Golda, MD, w Rajiv I. Nijhawan, MD, x Jerry Brewer, MD, v Addison Demer, MD, v Frederick Fish, MD, y Christopher B. Harmon, MD, z John Zitelli, MD, aa Thomas Knackstedt, MD, bb,cc Gaurav Singh, MD, dd Todd Mollet, MD, ee David R. Carr, MD, ff John G. Albertini, MD, gg Brent R. Moody, MD, hh Michel McDonald, MD, ii Jeremy S. Bordeaux, MD, jj Paul R. Massey, MD, kk Mollie A. MacCormack, MD, ll Allison Vidimos, MD, mm Christopher J. Arpey, MD, nn Sarah T. Arron, MD, oo Omar A. Ibrahimi, MD, pp S. Brian Jiang, MD, qq Christopher J. Miller, MD, rr Ian A. Maher, MD, z Ashley Wysong, MD, ss Barry Leshin, MD, tt Glenn D. Goldman, uu Nour Kibbi, MD, vv Hao Feng, MD, ww and Lindsey Collins, MD
doi : 10.1016/j.jaad.2023.10.069
Volume 90, Issue 4, April 2024, Pages 798-805
Metrics for Mohs: Responsible use of a potentially helpful tool
Murad Alam, MD
doi : 10.1016/j.jaad.2023.12.011
Volume 90, Issue 4, April 2024, Page 806
Petroleum jelly: A comprehensive review of its history, uses, and safety
Payvand Kamrani, DO, a Jamie Hedrick, MS, MBA, b James G. Marks, MD, a and Andrea L. Zaenglein, MD
doi : 10.1016/j.jaad.2023.06.010
Volume 90, Issue 4, April 2024, Pages 807-813
Zinc supplementation is associated with improvement in hand-foot skin reaction in patients on vascular endothelial growth factor receptor-tyrosine kinase inhibitors: A cohort study
Chun-Wei Lu, MD, a,b,c Chun-Nan Yeh, MD, d Hung- Chih Hsu, MD, PhD, e Chun-Bing Chen, MD, a,b,c Tsai-Sheng Yang, MD, e Yi-Ru Pan, PhD, d Wen- Hung Chung, MD, PhD, a,b,c and Shuen-Iu Hung, PhD
doi : 10.1016/j.jaad.2023.11.054
Volume 90, Issue 4, April 2024, Pages 814-815
Use of systemic Janus kinase inhibitors for dermatologic indications in the elderly: A retrospective study of 67 cases
M. Grace Hren, BS, and Saakshi Khattri, MD
doi : 10.1016/j.jaad.2023.11.055
Volume 90, Issue 4, April 2024, Pages 816-819
Association between atopic dermatitis and hypertension and hyperlipidemia: A cross-sectional study in the All of Us Research Program
Andrew E. Craver, BA, a Gloria F. Chen, BA, a and Jeffrey M. Cohen, MD
doi : 10.1016/j.jaad.2023.11.026
Volume 90, Issue 4, April 2024, Pages 819-821
Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study
Shaman Bhullar, MD, and Sean R. Christensen, MD, PhD
doi : 10.1016/j.jaad.2023.11.034
Volume 90, Issue 4, April 2024, Pages 821-822
Implementation of Mohs micrographic surgery at the VA New York Manhattan Harbor Healthcare System eliminated need for re-excision and decreased time to treatment: A retrospective and prospective cohort study
Jaclyn Rosenthal Himeles, MD, a Alexa Beth Steuer, MD, MPH, a Rachel Sally, BA, b Daniel Gutierrez, MD, a,c John G. Zampella, MD, a Mary L. Stevenson, MD, a John A. Carucci, MD, PhD, a and Nayoung Lee, MD a
doi : 10.1016/j.jaad.2023.11.035
Volume 90, Issue 4, April 2024, Pages 822-824
Physician- and patient-reported dermatologic comorbidities of hypermobile Ehlers-Danlos syndrome
Alan N. Snyder, MD, MSCR, a Almeera Lateef, BS, b Nicholas Strat, MSCR, a Laura Andrews, MD, MSCR, a Chelsea Shope, MD, MSCR, a Cortney Gensemer, PhD, c Bao Xin Liang, BS, d Taylor Petrucci, MS, c Mark Lavallee, MD, e Russel Norris, PhD, c and Dirk Elston, MD a
doi : 10.1016/j.jaad.2023.11.036
Volume 90, Issue 4, April 2024, Pages 824-826
Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
Catherina X. Pan, MD, a,b Mofei Liu, MSPH, c Charles B. Lau, BA, b,d William C. Lau, BA, b,e Daniel Y. Kim, BS, a,b Shahin A. Saberi, BS, a,b Rachael Rowley, BS, MS, b Ruhi Kanwar, BS, a,b Anita Giobbie-Hurder, MS, c Nicole R. LeBoeuf, MD, MPH, a,b,f and Vinod E. Nambudiri, MD, MBA, EdM
doi : 10.1016/j.jaad.2023.11.037
Volume 90, Issue 4, April 2024, Pages 826-829
Racial and ethnic differences in time to definitive surgery for melanoma: A retrospective study from the National Cancer Database
Jennifer M. Fernandez, MD, RD, a Tyler D. Evans, MD, a Makayla Schissel, MPH, b Alfredo Siller, Jr, MD, a Erin X. Wei, MD, a and Ashley Wysong, MD, MS
doi : 10.1016/j.jaad.2023.11.041
Volume 90, Issue 4, April 2024, Pages 829-831
Low local recurrence rates after Mohs micrographic surgery for cutaneous squamous cell carcinoma of the nail unit
Surya A. Veerabagu, MD, a Junqian Zhang, MD, b Aimee E. Krausz, MD, c William C. Fix, MD, d Brian Cheng, MD, e Joseph F. Sobanko, MD, b Jeremy R. Etzkorn, MD, b Thuzar M. Shin, MD, PhD, b H. William Higgins II, MD, MBE, b Cerrene N. Giordano, MD, b Stacy L. McMurray, MD, b Joanna L. Walker, MD, b and Christopher J. Miller, MD
doi : 10.1016/j.jaad.2023.11.043
Volume 90, Issue 4, April 2024, Pages 832-833
Wait times and health care utilization among refugee patients in dermatology: A retrospective chart review
Shawn Afvari, BS, a Mallory Zaino, MD, a Christina Kontzias, BA, a Mohammed Moumen, BSPH, a Shahla Namak, MD, b and Steven R. Feldman, MD, PhD
doi : 10.1016/j.jaad.2023.11.044
Volume 90, Issue 4, April 2024, Pages 834-835
Melanoma characteristics and overall survival predictors in American Indians and Alaska Natives: An analysis of the national cancer database from 2004 to 2018
Jennifer M. Fernandez, MD, RD, a Elizabeth M. Mata, MD, MSN, b Katherine Plampton, BS, a,c Melodi Javid Whitley, MD, PhD, a,d Adam V. Sutton, MD, MBA, a and Ashley Wysong, MD, MS
doi : 10.1016/j.jaad.2023.11.045
Volume 90, Issue 4, April 2024, Pages 836-837
Allocation of dermatology research opportunities to medical students: Analysis of the national academic dermatology approach
Jesper Ke, BA, a Severine Z. Cao, MD, b Allison M. Darland, MD, b Jane M. Grant-Kels, MD, c and Julie E. Mervak, MD
doi : 10.1016/j.jaad.2023.11.046
Volume 90, Issue 4, April 2024, Pages 838-839
TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases
Sarah E. Nocco, MD, a Mark D. Ewalt, MD, b Andrea P. Moy, MD, b Natasha E. Lewis, MD, b Menglei Zhu, MD, PhD, b Cecilia Lezcano, MD, b Klaus Busam, MD, b and Melissa Pulitzer, MD
doi : 10.1016/j.jaad.2023.11.051
Volume 90, Issue 4, April 2024, Pages 839-841
Role of thermoregulatory sweat test in the diagnosis of facial flushing: A retrospective case series
Rachel L. Ziebart, BSN, a Elizabeth A. Coon, MD, b and Julio C. Sartori-Valinotti, MD
doi : 10.1016/j.jaad.2023.11.052
Volume 90, Issue 4, April 2024, Pages 841-842
Mutational landscape of advanced extramammary Paget disease with comprehensive genomic profiling tests: A cohort study in a Japanese real-world setting
Okuto Iwasawa, MD, a Takuya Miyagawa, MD, PhD, a Jun Omatsu, MD, PhD, a Kazuki M. Matsuda, MD, PhD, a Kentaro Awaji,
doi : 10.1016/j.jaad.2023.11.057
Volume 90, Issue 4, April 2024, Pages 842-845
Hidradenitis suppurativa in transgender and gender diverse patients: A retrospective review with examination of the role of hormone therapy
Reese L. Imhof, MD, a Austin Todd, MS, b Caroline J. Davidge-Pitts, MB, BCh, c and Afsaneh Alavi, MD a
doi : 10.1016/j.jaad.2023.12.009
Volume 90, Issue 4, April 2024, Pages 845-847
Cutaneous melanoma incidence—Evidence of a flattening curve
Juliana Berk-Krauss, MD, a Medha Sharma, BA, a David Polsky, MD, PhD, b and Alan C. Geller, MPH, RN
doi : 10.1016/j.jaad.2023.12.010
Volume 90, Issue 4, April 2024, Pages 847-849
Distribution of shagreen patches and fibrous cephalic plaques in patients with tuberous sclerosis complex: A retrospective cohort study
Aya Takahashi, MD, PhD, a Satoshi Hattori, PhD, b,c Ena Sakai, MS, b Lingli Yang, MD, PhD, a Ichiro Katayama, MD, PhD, a Manabu Fujimoto, MD, PhD, a and Mari Wataya-Kaneda, MD, PhD
doi : 10.1016/j.jaad.2023.11.061
Volume 90, Issue 4, April 2024, Pages 849-852
MEFV variants are a predisposing factor for generalized pustular psoriasis
Takenori Yoshikawa, MD, PhD, a Takuya Takeichi, MD, PhD, a Kazuki Nishida, MD, PhD, b Yumiko Table I. Minor allele frequencies of MEFV variants in 24 cases of GPP versus control subjects Pheno-type Genotype Number of cases MAFs in this study Database MAFs in control subjects P value Odds ratio 95% lower CL 95% upper CL 24 GPP cases Glu84Lys 0/24 0/48 (0%) gnomAD 2/150 (1.3%) [.999 0.00 0.00 10.89 HGVD 31/1880 (1.6%) [.999 0.00 0.00 4.99 Glu148Gln 8/24 9/48 (18.8%) gnomAD 23/96 (24.0%) .530 0.73 0.29 1.77 HGVD 521/2382 (21.9%) .725 0.82 0.39 1.72 Arg202Gln 5/24 5/48 (10.4%) gnomAD 0/94 (0%) .004 Inf 2.00 Inf HGVD 76/2304 (3.3%) .023 3.41 1.25 8.75 Gly304Arg 1/24 1/48 (2.1%) gnomAD 5/146 (3.4%) [.999 0.60 0.03 4.58 HGVD 43/2126 (2.0%) [.999 1.03 0.05 6.04 Ser503Cys 3/24 3/48 (6.3%) gnomAD 2/152 (1.3%) .091 4.95 0.75 40.95 HGVD 5/216 (2.3%) .162 2.80 0.56 11.89 Statistical analyses could not be performed for p.Leu110Pro-p.Glu148Gln and p.Pro369Ser-Arg408Gln. (The MAFs of the 2 alleles with the tandem variants in the control subjects have not been published in the gnomAD nor in the HGVD.) CL, Confidence level; GPP, generalized pustular psoriasis; MAF, minor allele frequency. J AM ACAD D ERMATOL V OLUME 90, NUMBER 4 Research Letters 853 Kobayashi, BA, b Hozumi Sano, MD, c Akitaka Shibata, MD, PhD, d Haruka Koizumi, MD, a Reiko Tsutsumi, MD, PhD, e Ryo Fukaura, MD, a Masahiro Hayashi, MD, PhD, f Akiko Imanishi, MD, PhD, g Kenta Nakamura, MD, PhD,
doi : 10.1016/j.jaad.2023.10.070
Volume 90, Issue 4, April 2024, Pages 852-854
HLA DRB5∗01:01 is associated with pruritus in individuals with Fitzpatrick skin type IV-VI
Anusha Kambala, BS, Ahmad Rajeh, MS, Marina Z. Joel, BS, Emily Ma, BS, Hannah Cornman, BS, Jeni Zhang, BS, and Shawn G. Kwatra, MD
doi : 10.1016/j.jaad.2023.11.062
Volume 90, Issue 4, April 2024, Pages 855-857
Depression in patients with Raynaud’s phenomenon: A case-control study in the National Institutes of Health's All of Us Research Program
Gloria F. Chen, BA, a Katharina S. Shaw, MD, b Suzanne Xu, MD, a Kimberly B. Hashemi, MD, c Rochelle L. Castillo, MD, MS, c Ruth Ann Vleugels, MD, MPH, MBA, c and Jeffrey M. Cohen, MD
doi : 10.1016/j.jaad.2023.12.015
Volume 90, Issue 4, April 2024, Pages 857-859
Insurance coverage among the largest insurers per state for laser hair removal in the treatment of hidradenitis suppurativa
Sophia Ly, BA, a,b Priya Manjaly, BA, a,c Kanika Kamal, BA, a,d Nicholas Theodosakis, MD, PhD, d,e Alexandra Charrow, MD, a,d and Arash Mostaghimi, MD, MPA, MPH
doi : 10.1016/j.jaad.2023.12.016
Volume 90, Issue 4, April 2024, Pages 859-862
Granuloma annulare is associated with an increased risk of hematologic malignancies: A multicenter cohort study using TriNetX
David Garate, BS, a Christopher J. Thang, BS, a,b William Damsky, MD, PhD, c,d Misha Rosenbach, MD, e George Golovko, PhD, f Michael G. Wilkerson, MD, g and John S. Barbieri, MD, MBA
doi : 10.1016/j.jaad.2023.12.028
Volume 90, Issue 4, April 2024, Pages 862-864
Distribution of various demographic groups within the Medicare population at different Mohs medical practice settings
Annie He, BS, a Matthew J. Yan, BS, BA, b and Rajiv I. Nijhawan, MD
doi : 10.1016/j.jaad.2023.12.029
Volume 90, Issue 4, April 2024, Pages 864-866
Population-based mortality in hidradenitis suppurativa: A systematic review
Samiha T. Mohsen, MSc, a Emmanuel Suntres, BHSc, a Daud Manzar, BHSc, b Emma L. Price, MSc, a David Croitoru, MD, c and Cathryn Sibbald, MD
doi : 10.1016/j.jaad.2023.12.030
Volume 90, Issue 4, April 2024, Pages 866-867
Management of hidradenitis suppurativa tunnels using drainage setons: A retrospective multicentric study
Javier Fernandez-Vela, MD, a Jorge Roman?, MD, PhD, a Fernando Cabo, MD, b Mar?a Pousa, MD, b Gemma Cami~na, MD, c Antonio Guilabert, MD, a and Eva Vilarrasa, MD c
doi : 10.1016/j.jaad.2023.12.033
Volume 90, Issue 4, April 2024, Pages 868-870
Clinical features of rapid involuting congenital hemangioma: A prospective study
Tong Qiu, MD, a Zixin Zhang, MD, a Jiangyuan Zhou, MD, a Xue Gong, MD, a Xuepeng Zhang, MD, PhD, a Yuru Lan, MD, a Congxia Yang, MD, a YuJia Zhang, MD, a Zilong Zhou, MD, a Xian Jiang, MD, PhD, b Fan Hu, MD, c Wei Shan, MD, d Feiteng Kong, MD, e Yongbo Zhang, MD, e Qingxia Qiu, MD, f Siyuan Chen, MD, PhD, g and Yi Ji, MD, PhD
doi : 10.1016/j.jaad.2023.12.036
Volume 90, Issue 4, April 2024, Pages 870-872
A comparative analysis of keratoacanthomas and cutaneous squamous cell carcinoma treated with Mohs micrographic surgery
David X. Gao, MD, a David Ozog, MD, a,b Jalal Maghfour, MD, a Qing-Sheng Mi, MD, PhD, a,b and Jesse Veenstra, MD, PhD
doi : 10.1016/j.jaad.2023.12.045
Volume 90, Issue 4, April 2024, Pages 872-874
Dear Dr. Dermatoethics: Why is diversity in clinical trials important?
Akash Rau, BS, a and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2023.01.031
Volume 90, Issue 4, April 2024, Pages 875-876
Assessing the ethics of prior authorization denials and step therapy policies in dermatology
Tannaz Sedghi, MPH, a Christian Gronbeck, MD, b Donna A. Aiudi, MD, b and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2023.02.018
Volume 90, Issue 4, April 2024, Pages 877-878
JAAD Game Changer: Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: AÂ prospective multicenter study
Wendi E. Wohltmann, MD
doi : 10.1016/j.jaad.2023.09.017
Volume 90, Issue 4, April 2024, Page 878
Consulting ChatGPT: Ethical dilemmas in language model artificial intelligence
Eric J. Beltrami, BS, a and Jane Margaret Grant- Kels, MD
doi : 10.1016/j.jaad.2023.02.052
Volume 90, Issue 4, April 2024, Pages 879-880
JAAD Game Changer: Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: AÂ retrospective cohort study
Wendi E. Wohltmann, MD
doi : 10.1016/j.jaad.2023.09.018
Volume 90, Issue 4, April 2024, Page 880
Beyond JAAD April 2024
Andrew Bronin, MD
doi : 10.1016/j.jaad.2024.01.002
Volume 90, Issue 4, April 2024, Pages 882-884
Prolonging the lifespan of surgical markers during dermatologic surgery
Usamah M. Afzal, MD, a and Faisal R. Ali, PhD
doi : 10.1016/j.jaad.2023.03.029
Volume 90, Issue 4, April 2024, Pages e113-e114
Using dental floss pick and alternative packing material for ingrown toenails: A video demonstration
Yng Sun, MD, a Cheng-Che E. Lan, MD, PhD, a,b Tsung-Yu Tsai, MD, a,c and Sheng Yiao Lin, MD
doi : 10.1016/j.jaad.2023.04.012
Volume 90, Issue 4, April 2024, Pages e115-e116
An upside-down rotation flap to maintain beard symmetry for a large medial cheek defect
Michelle Juarez, MD, a and Rajiv I. Nijhawan, MD
doi : 10.1016/j.jaad.2023.04.041
Volume 90, Issue 4, April 2024, Pages e117-e118
Eleven blade for easier fenestration of outer table of bone
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.04.047
Volume 90, Issue 4, April 2024, Pages e119-e120
Use of hemostatic clips to reduce blood loss in between Mohs micrographic surgery stages
Aaditya Kumar, BS, a Daehee Jeong, BA, a,b Alexandria M. Riopelle, MD, c and Carl F. Schanbacher, MD
doi : 10.1016/j.jaad.2023.05.011
Volume 90, Issue 4, April 2024, Pages e121-e122
Repair of a combined nasal sidewall/cheek/medial canthus defect
Kevin Y. Shi, MD, PhD, a Andrew Matsumoto, MD, b and Rajiv I. Nijhawan, MD
doi : 10.1016/j.jaad.2023.04.064
Volume 90, Issue 4, April 2024, Pages e123-e124
Composite subcuticular subcutaneous buried suture
Ananya Sharma, MD, Ritu Sharma, MD, Kanika Sahni, MD, and Somesh Gupta, MD
doi : 10.1016/j.jaad.2023.05.032
Volume 90, Issue 4, April 2024, Pages e125-e126
Use of a slit knife in nail matrix surgery
Maria Gonzalez-Ramos, MD, Patricia Burgos-Blasco, MD, and Juan Jimenez-Cauhe, MD
doi : 10.1016/j.jaad.2023.05.044
Volume 90, Issue 4, April 2024, Pages e127-e128
Allgöwer-Donati suture: A technique to preserve skin microcirculation in dermatologic surgery
Lily Park, DO, a Zachary C. Lum, DO, b and Jayne S. Joo, MD
doi : 10.1016/j.jaad.2023.05.052
Volume 90, Issue 4, April 2024, Pages e129-e130
Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer
Yossi Cohen, BSc, a Mehrad Jaberi, MD, MSc, a,b Ivan V. Litvinov, MD, PhD, a,c,d and Yassein Shamout, MD, DABD
doi : 10.1016/j.jaad.2023.06.021
Volume 90, Issue 4, April 2024, Pages e131-e132
Dermatological perspectives on pressure alopecias: A call for awareness
Eduardo Corona-Rodarte, MD, a Luis Enrique Cano-Aguilar, MD, b Luisa Fernanda Baldassarri-Ortego, MD, c Antonella Tosti, MD, d and Daniel Asz-Sigall, MD
doi : 10.1016/j.jaad.2023.09.060
Volume 90, Issue 4, April 2024, Pages e133-e134
Antibiotics used to treat acne may be associated with inflammatory bowel disease: Response to Kridin et al “Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study�
Chih-Yin Lin, MD, a and Chun-An Yao, MD
doi : 10.1016/j.jaad.2023.09.088
Volume 90, Issue 4, April 2024, Pages e135-e136
Isotretinoin is not associated with inflammatory bowel disease even when compared with topical antibiotics and topical retinoids
Khalaf Kridin, MD, PhD, a,b,c and Ralf J. Ludwig, MD a,
doi : 10.1016/j.jaad.2023.11.004
Volume 90, Issue 4, April 2024, Pages e137-e138
Tracing the origins of setons in hidradenitis suppurativa: A commentary to Vilarrasa et al’s “Drainage setons for the management of sinus tracts in hidradenitis suppurativa�
Inigo Navarro-Fernandez, MD
doi : 10.1016/j.jaad.2023.10.068
Volume 90, Issue 4, April 2024, Page e139
Response letter to “Tracing the origins of setons in hidradenitis suppurativa: A commentary to Vilarrasa et al’s ‘Drainage setons for the management of sinus tracts in hidradenitis suppurativa’�
Gemma Cami~na-Conforto, MD, a Eva Vilarrasa, MD, PhD, a Fernando Cabo, MD, b Javier Fernandez-Vela, MD, c Mar?a Pousa, MD, b and Jorge Roman?, MD, PhD
doi : 10.1016/j.jaad.2023.11.049
Volume 90, Issue 4, April 2024, Pages e141-e142
Response to John et al’s comments of “paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the prospective rosacea refractory erythema randomized clinical trial�
Ben Wang, MD, a,b,c Yingxue Huang, MD, a,b,c and Ji Li, MD, PhD
doi : 10.1016/j.jaad.2023.11.050
Volume 90, Issue 4, April 2024, Pages e143-e144
Response to Wang et al., “Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial�
John Sauer, Jr, BA, and Nicholas Zanghi, BS
doi : 10.1016/j.jaad.2023.08.113
Volume 90, Issue 4, April 2024, Pages e145-e146
Response to “Ethically Conducting Hair Examinations among Individuals with Hijabs�
Amina Ziad, BA, a,b and Layla Al-Zubi, BA
doi : 10.1016/j.jaad.2023.11.063
Volume 90, Issue 4, April 2024, Pages e147-e148
Response to “ethically conducting hair examinations among individuals with hijabs''
Warda Abdi, BA, a Lisa Bateganya, BS, a and Travis W. Blalock, MD
doi : 10.1016/j.jaad.2023.12.022
Volume 90, Issue 4, April 2024, Pages e149-e150
Review of Dermatology, Second Edition
Stephanie Munie, BS
doi : 10.1016/j.jaad.2023.12.008
Volume 90, Issue 4, April 2024, Page e151
Procedures in cosmetic dermatology: Soft tissue augmentation, fifth edition
Alanoud Alhadyani, MD
doi : 10.1016/j.jaad.2023.12.012
Volume 90, Issue 4, April 2024, Page e153
April 2024 iotaderma (#362)
Robert I. Rudolph, MD, FACP
doi : 10.1016/j.jaad.2023.11.001
Volume 90, Issue 4, April 2024, Page e155
